Only CD@ ( + ) / CD@ ( high ) / CD@ ( high ) / CD@ ( + ) and CD@ ( + ) / CD@ ( high ) / CD@ ( high ) / CXCR@ ( + ) cells had significant higher frequency in patients under cycloporine treatment when compared to those under belatacept .